Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 126.58M | $ 42.31M | $ 73.77M | $ 10.5M |
3/31/2025 | $ 138.52M | $ 125.11M | $ 2.91M | $ 10.5M |
12/31/2024 | $ 150.73M | $ 134.56M | $ 5.67M | $ 10.5M |
9/30/2024 | $ 98.45M | $ 81.9M | $ 6.05M | $ 10.5M |
6/30/2024 | $ 108.31M | $ 93.43M | $ 4.38M | $ 10.5M |
3/31/2024 | $ 123.73M | $ 110.18M | $ 3.04M | $ 10.5M |
12/31/2023 | $ 20.99M | $ 7.42M | $ 3.08M | $ 10.5M |
9/30/2023 | $ 29.27M | $ 10.18M | $ 4.68M | $ 14.41M |
6/30/2023 | $ 24.23M | $ 6.32M | $ 3.5M | $ 14.41M |
3/31/2023 | $ 36.23M | $ 16.75M | $ 5.08M | $ 14.41M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for AVALO THERAPEUTICS INC is calculated as follows: Assets [ $ 59.19M ] - Intangibles [ $ 16.3M ] - CashnEq [ $ 33.52M ]
(=) Core Assets [ $ 9.37M ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |